T.Lamote SRL
T.Lamote reported total assets of 663,074 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Aug 2026).
The score of T.Lamote shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +4 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
T.Lamote's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 55,422 € | ||||
| Equity | 404,156 € | ||||
| Cash | 4,529 € | ||||
| EBITDA | 101,794 € | ||||
| Total assets | 663,074 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
T.Lamote's financial analysis
- Solvency61.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of T.Lamote
T.Lamote's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0884.827.664
- VAT number
- BE0884827664
- Peppol
- Registered · 0208:0884827664 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Nov 2006
- Registered office
- 1785 Merchtem
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
T.Lamote (SRL) has been based in Merchtem since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 55,422 € and equity of 404,156 €; its revenue is not published. Its solvency stands at 61.0%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to T.Lamote
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vercruysse Retail sale of pharmaceutical products Bruges · balance sheet 662,948 €
- Natural Pharma Retail sale of pharmaceutical products Brussels · balance sheet 662,921 €
- Aa.Pharma Oosthoven Retail sale of pharmaceutical products Oud-Turnhout · balance sheet 663,534 €
- Corums Retail sale of pharmaceutical products Halle · balance sheet 662,462 €
- Pharmacie Anne Gilson Retail sale of pharmaceutical products Houffalize · balance sheet 663,961 €
- Henrion-Fourez Retail sale of pharmaceutical products Brunehaut · balance sheet 661,950 €
- Sophie Verreydt Retail sale of pharmaceutical products Lokeren · balance sheet 661,590 €
- Van de Weyer Apotheek Retail sale of pharmaceutical products Landen · balance sheet 661,590 €
Frequently asked questions about T.Lamote
What is the revenue of T.Lamote?
T.Lamote files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of T.Lamote?
In Belgium, the VAT number is the company number prefixed with BE: BE0884827664 for T.Lamote, if the company is VAT-registered. Its company number (CBE) is 0884.827.664.
Where is the registered office of T.Lamote?
According to the CBE register, the registered office of T.Lamote is in 1785 Merchtem.
What is the equity of T.Lamote?
At the close of the 2025 financial year, the equity of T.Lamote amounts to 404,156 €, a solvency of 61.0% of total assets.
Who manages T.Lamote?
The register lists 1 active mandates at T.Lamote. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of T.Lamote
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →